Position history for BlackRock, Inc.'s holdings in CYTOKINETICS INC
BlackRock, Inc. holds 16.5M shares of CYTK (CYTOKINETICS INC), worth $1.1B as of 2026-Q1. The position was increased (+0.9% shares). CYTK represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$1.1B
Current Shares
16.5M
Total Value Change
+$363M
Total Shares Change
+1.1M
Other major holders of CYTK: BlackRock Finance, Inc., FMR LLC, VANGUARD GROUP INC
Increased |
| 16.5M |
+0.9% |
| $1.1B |
| 0.0% |
| $60.72 |
32 |
| 2025-Q4 | Increased | 16.4M | +5.6% | $1B | 0.0% | $61.37 | 34 |
| 2025-Q3 | Decreased | 15.5M | -1.0% | $853.3M | 0.0% | $53.89 | 0 |
| 2025-Q2 | Increased | 15.7M | +0.7% | $518M | 0.0% | $33.16 | 31 |
| 2025-Q1 | Increased | 15.6M | +0.6% | $625.5M | 0.0% | $43.19 | 32 |
| 2024-Q4 | New | 15.5M | - | $727.7M | 0.0% | $47.15 | 44 |